Insider Transactions in Q4 2025 at Cross Country Healthcare Inc (CCRN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2025
|
Karen Mote Pres., Cross Country Locums |
BUY
Grant, award, or other acquisition
|
Direct |
8,095
+19.99%
|
-
|
|
Dec 18
2025
|
Phillip Lyn Noe Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,826
+35.66%
|
-
|
|
Dec 18
2025
|
James V. Redd Iii Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,311
+28.35%
|
-
|
|
Dec 18
2025
|
Dwayne Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,680
+37.38%
|
-
|
|
Dec 18
2025
|
Venkat Bhamidipati Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,680
+38.56%
|
-
|
|
Dec 18
2025
|
W Larry Cash Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,680
+7.72%
|
-
|
|
Dec 18
2025
|
Gale S Fitzgerald Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,680
+14.04%
|
-
|
|
Dec 18
2025
|
Janice Elizabeth Nevin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,680
+27.76%
|
-
|
|
Dec 18
2025
|
Susan E Ball General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
35,804
+14.46%
|
-
|
|
Dec 18
2025
|
William J. Burns Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,370
+14.88%
|
-
|
|
Dec 18
2025
|
Kevin Cronin Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,672
+16.74%
|
-
|
|
Dec 18
2025
|
Cynthia Ann Grieco VP, Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
11,288
+39.04%
|
-
|
|
Dec 18
2025
|
Marc S. Krug Group President, Delivery |
BUY
Grant, award, or other acquisition
|
Direct |
23,817
+28.87%
|
-
|
|
Dec 18
2025
|
Colin Patrick Mc Donald Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,340
+21.42%
|
-
|
|
Dec 09
2025
|
W Larry Cash Director |
BUY
Open market or private purchase
|
Direct |
5,000
+1.2%
|
$40,000
$8.14 P/Share
|